Elisabeth Lundqvist Åvall

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: CLINICAL CANCER RESEARCH. 2017;23(5):1227-1235

Targeted Sequencing Reveals Low-Frequency Variants in EPHA Genes as Markers of Paclitaxel-Induced Peripheral Neuropathy.

Apellániz-Ruiz M; Tejero H; Inglada-Pérez L; Sánchez-Barroso L; Gutiérrez-Gutiérrez G; Calvo I; Castelo B; Redondo A; García-Donás J; Romero-Laorden N; Sereno M; Merino M; Currás-Freixes M; Montero-Conde C; Mancikova V; Åvall-Lundqvist E; Green H; Al-Shahrour F; Cascón A; Robledo M; Rodríguez-Antona C
Article: BRITISH JOURNAL OF CANCER. 2017;116(4):455-463

Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist).

Lindemann K; Gibbs E; Åvall-Lundqvist E; dePont Christensen R; Woie K; Kalling M; Auranen A; Grenman S; Hoegberg T; Rosenberg P; Skeie-Jensen T; Hjerpe E; Dørum A; Gebski V; Kristensen G
Article: GYNECOLOGIC ONCOLOGY. 2017;144(1):167-173

Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG).

Dahm-Kähler P; Borgfeldt C; Holmberg E; Staf C; Falconer H; Bjurberg M; Kjölhede P; Rosenberg P; Stålberg K; Högberg T; Åvall-Lundqvist E
Article: ACTA ONCOLOGICA. 2016;55(11):1285-1293

Defecation into clothing without forewarning and mean radiation dose to bowel and anal-sphincter among gynecological cancer survivors.

Lind H; Alevronta E; Steineck G; Waldenström A-C; Nyberg T; Olsson C; Wilderäng U; Dunberger G; Al-Abany M; Åvall-Lundqvist E
Article: RADIOTHERAPY AND ONCOLOGY. 2016;120(3):537-541

Time-dependent dose-response relation for absence of vaginal elasticity after gynecological radiation therapy.

Alevronta E; Åvall-Lundqvist E; Al-Abany M; Nyberg T; Lind H; Waldenström A-C; Olsson C; Dunberger G; Bergmark K; Steineck G; Lind BK
Article: ONCOTARGET. 2016;7(14):18573-18584

Markers of fibroblast-rich tumor stroma and perivascular cells in serous ovarian cancer: Inter- and intra-patient heterogeneity and impact on survival.

Corvigno S; Wisman GBA; Mezheyeuski A; van der Zee AGJ; Nijman HW; Åvall-Lundqvist E; Östman A; Dahlstrand H
Article: INTERNATIONAL JOURNAL OF CANCER. 2016;138(1):98-109

Phylogenetic analysis of multiple FISH markers in oral tongue squamous cell carcinoma suggests that a diverse distribution of copy number changes is associated with poor prognosis.

Wangsa D; Chowdhury SA; Ryott M; Gertz EM; Elmberger G; Auer G; Åvall Lundqvist E; Küffer S; Ströbel P; Schäffer AA; Schwartz R; Munck-Wikland E; Ried T; Heselmeyer-Haddad K
Article: LAKARTIDNINGEN. 2015;112:DLUI

[Paradigm shift in gynecological cancer].

Åvall Lundqvist E
Article: LAKARTIDNINGEN. 2015;112:DLUH

[Hope for improvement of survival in ovarian cancer].

Högberg T; Bergfeldt K; Borgfeldt C; Holmberg E; Åvall Lundqvist E
Article: INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS. 2015;131 Suppl 2:S150-S152

Targeted therapy in gynecologic cancers: Ready for prime time?

Seoud M; Lundqvist EÅ; Fujiwara K
Article: INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS. 2015;131 Suppl 2:S146-S149

Principles of chemotherapy.

Lundqvist EÅ; Fujiwara K; Seoud M
Article: ACTA ONCOLOGICA. 2015;54(5):772-779

Reduced vaginal elasticity, reduced lubrication, and deep and superficial dyspareunia in irradiated gynecological cancer survivors.

Stinesen Kollberg K; Waldenström A-C; Bergmark K; Dunberger G; Rossander A; Wilderäng U; Åvall-Lundqvist E; Steineck G
Article: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2014;24(9):1693-1699

Quality of life and patient-reported outcomes in endometrial cancer clinical trials: a call for action!

Joly F; McAlpine J; Nout R; Åvall-Lundqvist E; Shash E; Friedlander M; Gynaecologic Cancer InterGroup (GCIG)
Article: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2014;24(9):1686-1692

Quality of life research in endometrial cancer: what is needed to advance progress in this disease site? Methodological considerations from the Gynecologic Cancer InterGroup Symptom Benefit Working Group brainstorming session, Leiden 2012.

McAlpine JN; Greimel E; Brotto LA; Nout RA; Shash E; Avall-Lundqvist E; Friedlander ML; Joly F; Gynecologic Cancer InterGroup (GCIG)
Article: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2014;24(8):1389-1394

Metabolic markers and HSP60 in chemonaive serous solid ovarian cancer versus ascites.

Hjerpe E; Brage SE; Frostvik Stolt M; Johansson H; Shoshan M; Avall-Lundqvist E
Article: BMC CANCER. 2014;14:68

Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO).

Lindemann K; Malander S; Christensen RD; Mirza MR; Kristensen GB; Aavall-Lundqvist E; Vergote I; Rosenberg P; Boman K; Nordstrøm B
Article: BMC CLINICAL PATHOLOGY. 2013;13(1):30

Metabolic markers GAPDH, PKM2, ATP5B and BEC-index in advanced serous ovarian cancer.

Hjerpe E; Egyhazi Brage S; Carlson J; Frostvik Stolt M; Schedvins K; Johansson H; Shoshan M; Avall-Lundqvist E
Article: SUPPORTIVE CARE IN CANCER. 2013;21(11):3063-3070

Lower limb lymphedema in gynecological cancer survivors--effect on daily life functioning.

Dunberger G; Lindquist H; Waldenström A-C; Nyberg T; Steineck G; Åvall-Lundqvist E
Article: JOURNAL OF MEDICAL GENETICS. 2013;50(9):599-605

Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy.

Leandro-García LJ; Inglada-Pérez L; Pita G; Hjerpe E; Leskelä S; Jara C; Mielgo X; González-Neira A; Robledo M; Avall-Lundqvist E; Gréen H; Rodríguez-Antona C
Article: ACTA ONCOLOGICA. 2013;52(4):719-726

Dose-response relationships for an atomized symptom of fecal incontinence after gynecological radiotherapy.

Alevronta E; Lind H; Al-Abany M; Waldenström A-C; Olsson C; Dunberger G; Mavroidis P; Nyberg T; Johansson K-A; Åvall-Lundqvist E; Steineck G; Lind BK
Article: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2013;23(3):448-455

HSP60 predicts survival in advanced serous ovarian cancer.

Hjerpe E; Egyhazi S; Carlson J; Stolt MF; Schedvins K; Johansson H; Shoshan M; Avall-Lundqvist E
Article: JOURNAL OF MEDICAL ETHICS. 2013;39(1):41-45

Cancer survivors' perception of participation in a long-term follow-up study.

Dunberger G; Thulin H; Waldenström A-C; Lind H; Henningsohn L; Åvall-Lundqvist E; Steineck G; Kreicbergs U
Article: ANNALS OF ONCOLOGY. 2012;23(10):2613-2619

First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)--a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG.

Lindemann K; Christensen RD; Vergote I; Stuart G; Izquierdo MA; Kærn J; Havsteen H; Eisenhauer E; Ridderheim M; Lopez AB; Hirte H; Aavall-Lundquvist E; Vrdoljak E; Green J; Kristensen GB
Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2012;84(2):428-436

Relative importance of hip and sacral pain among long-term gynecological cancer survivors treated with pelvic radiotherapy and their relationships to mean absorbed doses.

Waldenström A-C; Olsson C; Wilderäng U; Dunberger G; Lind H; Alevronta E; al-Abany M; Tucker S; Åvall-Lundqvist E; Johansson K-A; Steineck G
Article: INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS. 2012;119 Suppl 2:S151-S154

Principles of chemotherapy.

Lundqvist EÅ
Article: BMC CANCER. 2012;12:359

Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites.

Wintzell M; Hjerpe E; Åvall Lundqvist E; Shoshan M
Article: CLINICAL CANCER RESEARCH. 2012;18(16):4441-4448

Regulatory polymorphisms in β-tubulin IIa are associated with paclitaxel-induced peripheral neuropathy.

Leandro-García LJ; Leskelä S; Jara C; Gréen H; Avall-Lundqvist E; Wheeler HE; Dolan ME; Inglada-Perez L; Maliszewska A; de Cubas AA; Comino-Méndez I; Mancikova V; Cascón A; Robledo M; Rodríguez-Antona C
Article: JOURNAL OF PHARMACEUTICAL SCIENCES. 2011;100(10):4205-4209

Impact of CYP3A5*3 and CYP2C8-HapC on paclitaxel/carboplatin-induced myelosuppression in patients with ovarian cancer.

Gréen H; Khan MS; Jakobsen-Falk I; Åvall-Lundqvist E; Peterson C
Article: BRITISH JOURNAL OF CANCER. 2011;105(6):737-745

Late symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study.

Lind H; Waldenström A-C; Dunberger G; al-Abany M; Alevronta E; Johansson K-A; Olsson C; Nyberg T; Wilderäng U; Steineck G; Åvall-Lundqvist E
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2011;90(8):917-920

Subspecialist training in surgical gynecologic oncology in the Nordic countries.

Antonsen SL; Avall-Lundqvist E; Salvesen HB; Auranen A; Salvarsdottir A; Høgdall C; Nordic Society of Gynaecological Oncology
Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2011;80(4):1171-1180

Pain and mean absorbed dose to the pubic bone after radiotherapy among gynecological cancer survivors.

Waldenström A-C; Olsson C; Wilderäng U; Dunberger G; Lind H; al-Abany M; Palm Å; Avall-Lundqvist E; Johansson K-A; Steineck G
Article: ACTA ONCOLOGICA. 2011;50(2):233-242

Loose stools lead to fecal incontinence among gynecological cancer survivors.

Dunberger G; Lind H; Steineck G; Waldenström A-C; Onelöv E; Avall-Lundqvist E
Article: JOURNAL OF CLINICAL ONCOLOGY. 2010;28(27):4162-4169

Phase III trial of carboplatin plus paclitaxel with or without gemcitabine in first-line treatment of epithelial ovarian cancer.

du Bois A; Herrstedt J; Hardy-Bessard A-C; Müller H-H; Harter P; Kristensen G; Joly F; Huober J; Avall-Lundqvist E; Weber B; Kurzeder C; Jelic S; Pujade-Lauraine E; Burges A; Pfisterer J; Gropp M; Staehle A; Wimberger P; Jackisch C; Sehouli J
Article: JOURNAL OF CLINICAL ONCOLOGY. 2010;28(20):3323-3329

Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse.

Pujade-Lauraine E; Wagner U; Aavall-Lundqvist E; Gebski V; Heywood M; Vasey PA; Volgger B; Vergote I; Pignata S; Ferrero A; Sehouli J; Lortholary A; Kristensen G; Jackisch C; Joly F; Brown C; Le Fur N; du Bois A
Article: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2010;20(3):449-460

Fecal incontinence affecting quality of life and social functioning among long-term gynecological cancer survivors.

Dunberger G; Lind H; Steineck G; Waldenström A-C; Nyberg T; al-Abany M; Nyberg U; Avall-Lundqvist E
Article: EUROPEAN JOURNAL OF CANCER. 2010;46(3):606-615

Self-reported symptoms of faecal incontinence among long-term gynaecological cancer survivors and population-based controls.

Dunberger G; Lind H; Steineck G; Waldenström A-C; Nyberg T; Al-Abany M; Nyberg U; Vall-Lundqvist E
Article: AMERICAN JOURNAL OF PATHOLOGY. 2009;175(6):2637-2645

Fluorescence in situ hybridization markers for prediction of cervical lymph node metastases.

Wangsa D; Heselmeyer-Haddad K; Ried P; Eriksson E; Schäffer AA; Morrison LE; Luo J; Auer G; Munck-Wikland E; Ried T; Lundqvist EA
Article: MOLECULAR CANCER THERAPEUTICS. 2009;8(7):1916-1923

Ovarian carcinoma cells with low levels of beta-F1-ATPase are sensitive to combined platinum and 2-deoxy-D-glucose treatment.

Hernlund E; Hjerpe E; Avall-Lundqvist E; Shoshan M
Article: EUROPEAN JOURNAL OF CANCER. 2009;45(9):1700-1708

EGFR protein overexpression and gene copy number increases in oral tongue squamous cell carcinoma.

Ryott M; Wangsa D; Heselmeyer-Haddad K; Lindholm J; Elmberger G; Auer G; Avall Lundqvist E; Ried T; Munck-Wikland E
Article: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2009;104(2):130-137

Pharmacogenetic studies of Paclitaxel in the treatment of ovarian cancer.

Gréen H; Söderkvist P; Rosenberg P; Mirghani RA; Rymark P; Lundqvist EA; Peterson C
Article: BRITISH JOURNAL OF CANCER. 2008;99(7):1121-1128

Ki-67 expression predicts locoregional recurrence in stage I oral tongue carcinoma.

Wangsa D; Ryott M; Avall-Lundqvist E; Petersson F; Elmberger G; Luo J; Ried T; Auer G; Munck-Wikland E
Article: BRITISH JOURNAL OF CANCER. 2006;94(11):1683-1689

Expression of DNA damage response proteins and complete remission after radiotherapy of stage IB-IIA of cervical cancer.

Beskow C; Kanter L; Holgersson A; Nilsson B; Frankendal B; Avall-Lundqvist E; Lewensohn R
Article: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2006;16(3):1130-1139

Lymphedema and bladder-emptying difficulties after radical hysterectomy for early cervical cancer and among population controls.

Bergmark K; Avall-Lundqvist E; Dickman PW; Henningsohn L; Steineck G
Article: JOURNAL OF SEX & MARITAL THERAPY. 2005;31(5):361-383

Synergy between sexual abuse and cervical cancer in causing sexual dysfunction.

Bergmark K; Avall-Lundqvist E; Dickman PW; Steineck G; Henningsohn L
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2005;40(6):654-661

Effect of chemotherapy on circulating gastrointestinal hormone levels in ovarian cancer patients: relationship to nausea and vomiting.

Hursti TJ; Börjeson S; Hellström PM; Avall-Lundqvist E; Stock S; Steineck G; Peterson C
Article: ANNALS OF ONCOLOGY. 2005;16 Suppl 8:viii7-viii12

2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004).

du Bois A; Quinn M; Thigpen T; Vermorken J; Avall-Lundqvist E; Bookman M; Bowtell D; Brady M; Casado A; Cervantes A; Eisenhauer E; Friedlaender M; Fujiwara K; Grenman S; Guastalla JP; Harper P; Hogberg T; Kaye S; Kitchener H; Kristensen G; Mannel R; Meier W; Miller B; Neijt JP; Oza A; Ozols R; Parmar M; Pecorelli S; Pfisterer J; Poveda A; Provencher D; Pujade-Lauraine E; Randall M; Rochon J; Rustin G; Sagae S; Stehman F; Stuart G; Trimble E; Vasey P; Vergote I; Verheijen R; Wagner U; Gynecologic Cancer Intergroup; AGO-OVAR; ANZGOG; EORTC; GEICO; GINECO; GOG; JGOG; MRC/NCRI; NCIC-CTG; NCI-US; NSGO; RTOG; SGCTG; IGCS; Organizational team of the two prior International
Article: ANNALS OF ONCOLOGY. 2005;16 Suppl 8:viii39-viii42

The Gynecologic Cancer Intergroup (GCIG): history and current status.

Vermorken JB; Avall-Lundqvist E; Pfisterer J; Bacon M; GCIG; AGO-OVAR; ANZGOG; EORTC-GCC; GEICO; GINECO; GOG; JGOG; MRC; NCIC-CTG; NCI-US; NSGO; RTOG; SGCTG
Article: ANNALS OF ONCOLOGY. 2005;16 Suppl 8:viii36-viii38

3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration.

Stuart G; Avall-Lundqvist E; du Bois A; Bookman M; Bowtell D; Brady M; Casado A; Cervantes A; Eisenhauer E; Friedlaender M; Fujiwara K; Grenman S; Guastalla JP; Harper P; Hogberg T; Kaye S; Kitchener H; Kristensen G; Mannel R; Meier W; Miller B; Oza A; Ozols R; Parmar M; Pfisterer J; Poveda A; Provencher D; Pujade-Lauraine E; Quinn M; Randall M; Rochon J; Rustin G; Sagae S; Stehman F; Trimble E; Thigpen T; Vasey P; Vergote I; Verheijen R; Vermorken J; Wagner U; NCIC-CTG; NSGO; AGO-OVAR; GOG; ANZGOG; EORTC; GEICO; JGOG; GINECO; MRC/NCRI; SGCTG; RTOG; NCI-US
Article: ANNALS OF ONCOLOGY. 2005;16 Suppl 8:viii30-viii35

Integration of new or experimental treatment options and new approaches to clinical trials.

Quinn M; Pfisterer J; Avall-Lundqvist E; Bookman M; Bowtell D; Casado A; Cervantes A; Grenman S; Harper P; Oza A; Pecorelli S; Pujade-Lauraine E; Trimble E; Vasey P; Wagner U; ANZGOG; AGO-OVAR; NSGO; GOG; EORTC; GEICO; MRC/NCRI; NCIC-CTG; IGCS; GINECO; NCI-US; SGCTG
Article: INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY. 2004;23(3):215-222

Laminin-5 gamma2 chain expression facilitates detection of invasive squamous cell carcinoma of the uterine cervix.

Stoltzfus P; Salo S; Eriksson E; Aspenblad U; Tryggvason K; Auer G; Avall-Lundqvist E
Article: GYNECOLOGIC ONCOLOGY. 2004;93(2):484-492

A population-based study of cervical carcinoma and HPV infection in Latvia.

Silins I; Wang X; Tadesse A; Jansen KU; Schiller JT; Avall-Lundqvist E; Frankendal B; Dillner J
Article: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2003;13 Suppl 2:172-177

First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin.

Kristensen GB; Vergote I; Stuart G; Del Campo JM; Kaern J; Lopez AB; Eisenhauer E; Aavall-Lundquist E; Ridderheim M; Havsteen H; Mirza MR; Scheistroen M; Vrdoljak E
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2002;81(5):443-450

Patient-rating of distressful symptoms after treatment for early cervical cancer.

Bergmark K; Avall-Lundqvist E; Dickman PW; Henningsohn L; Steineck G
Article: GYNECOLOGIC ONCOLOGY. 2002;85(2):333-338

Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients.

Silins I; Avall-Lundqvist E; Tadesse A; Jansen KU; Stendahl U; Lenner P; Zumbach K; Pawlita M; Dillner J; Frankendal B
Article: LAKARTIDNINGEN. 2000;97(46):5347-5355

[A Swedish study of women treated for cervix cancer. Gynecologic cancer often affects sexuality].

Bergmark K; Lundqvist EA; Steineck G
Article: SUPPORTIVE CARE IN CANCER. 2000;8(5):431-434

Aspects of delayed chemotherapy-induced nausea. Dexamethasone and adrenal response patterns in patients and healthy volunteers.

Lundström S; Fürst CJ; Börjeson S; Steineck G; Avall-Lundqvist E; Hursti TJ; Peterson C; Fredrikson M
Article: JOURNAL OF GENERAL VIROLOGY. 1999;80 ( Pt 11):2931-2936

Serological evidence for protection by human papillomavirus (HPV) type 6 infection against HPV type 16 cervical carcinogenesis.

Silins I; Wang Z; Åvall-Lundqvist E; Frankendal B; Vikmanis U; Sapp M; Schiller JT; Dillner J
Article: NEW ENGLAND JOURNAL OF MEDICINE. 1999;340(18):1383-1389

Vaginal changes and sexuality in women with a history of cervical cancer.

Bergmark K; Avall-Lundqvist E; Dickman PW; Henningsohn L; Steineck G
Article: EUROPEAN JOURNAL OF CANCER. 1997;33(11):1799-1804

The impact of tumour angiogenesis, p53 overexpression and proliferative activity (MIB-1) on survival in squamous cervical carcinoma.

Avall-Lundqvist EH; Silfverswärd C; Aspenblad U; Nilsson BR; Auer GU
Article: CANCER NURSING. 1997;20(4):260-266

Similarities and differences in assessing nausea on a verbal category scale and a visual analogue scale.

Börjeson S; Hursti TJ; Peterson C; Fredikson M; Fürst CJ; Avall-Lundqvist E; Steineck G
Article: JOURNAL OF MEDICAL VIROLOGY. 1997;52(4):436-440

Human papillomavirus antibody responses among patients with incident cervical carcinoma.

Wang Z; Konya J; Avall-Lundkvist E; Sapp M; Dillner J; Dillner L
Article: SUPPORTIVE CARE IN CANCER. 1996;4(6):440-446

Single high-dose dexamethasone improves the effect of ondansetron on acute chemotherapy-induced nausea and vomiting but impairs the control of delayed symptoms.

Peterson C; Hursti TJ; Börjeson S; Avall-Lundqvist E; Fredrikson M; Fürst CJ; Lomberg H; Steineck G
Article: BRITISH JOURNAL OF CANCER. 1996;74(7):1114-1119

Impact of tumour burden on chemotherapy-induced nausea and vomiting.

Hursti TJ; Avall-Lundqvist E; Börjeson S; Fredrikson M; Fürst CJ; Steineck G; Peterson C
Article: ONCOLOGY REPORTS. 1995;2(4):619-623

Serum levels of scc, cea, ca-125 and tpa in the management of cervical-carcinoma.

Avalllundqvist E; Schedvins K; Sjovall K; Eneroth P
Article: CANCER EPIDEMIOLOGY. 1995;19(5):381-393

Association of serum antibodies against defined epitopes of human papillomavirus L1, E2, and E7 antigens and of HPV DNA with incident cervical cancer.

Dillner L; Zellbi A; Avall-Lundqvist E; Heino P; Eklund C; Pettersson CA; Forslund O; Hansson BG; Grandien M; Bistoletti P
Visa fler

Alla övriga publikationer

Review: LAKARTIDNINGEN. 2015;112:DLUF

[Individualized treatment for ovarian cancer may become possible].

Kjölhede P; Dahm-Kähler P; Tholander B; Åvall Lundqvist E
Letter: CLINICAL CANCER RESEARCH. 2015;21(13):3092-3093

Replication of Genetic Polymorphisms Reported to Be Associated with Taxane-Related Sensory Neuropathy in Patients with Early Breast Cancer Treated with Paclitaxel--letter.

Apellániz-Ruiz M; Sánchez-Barroso L; Gutiérrez-Gutiérrez G; Sereno M; García-Donás J; Åvall-Lundqvist E; Gréen H; Brøsen K; Bergmann TK; Rodríguez-Antona C
Review: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2014;24(9 Suppl 3):S26-S29

Gynecologic Cancer InterGroup (GCIG) consensus review for squamous cell carcinoma of the ovary.

Glasspool RM; González Martín A; Millan D; Lorusso D; Åvall-Lundqvist E; Hurteau JA; Davis A; Hilpert F; Kim J-W; Alexandre J; Ledermann JA
Review: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2014;24(9 Suppl 3):S30-S34

Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian small cell cancers.

Reed NS; Pautier P; Åvall-Lundqvist E; Choi C-H; du Bois A; Friedlander M; Fyles A; Kichenadasse G; Provencher DM; Ray-Coquard I
Review: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2014;24(9 Suppl 3):S102-S108

Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervix.

Satoh T; Takei Y; Treilleux I; Devouassoux-Shisheboran M; Ledermann J; Viswanathan AN; Mahner S; Provencher DM; Mileshkin L; Åvall-Lundqvist E; Pautier P; Reed NS; Fujiwara K
Review: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2014;24(9 Suppl 3):S117-S122

Gynecologic Cancer InterGroup (GCIG) consensus review for vulvovaginal melanomas.

Leitao MM; Cheng X; Hamilton AL; Siddiqui NA; Jurgenliemk-Schulz I; Mahner S; Åvall-Lundqvist E; Kim K; Freyer G
Review: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2011;21(4):771-775

Clinical trials in recurrent ovarian cancer.

Friedlander M; Trimble E; Tinker A; Alberts D; Avall-Lundqvist E; Brady M; Harter P; Pignata S; Pujade-Lauraine E; Sehouli J; Vergote I; Beale P; Bekkers R; Calvert P; Copeland L; Glasspool R; Gonzalez-Martin A; Katsaros D; Kim JW; Miller B; Provencher D; Rubinstein L; Atri M; Zeimet A; Bacon M; Kitchener H; Stuart GCE; Gynecologic Cancer InterGroup
Meeting abstract: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2010;78(3):S706

Dose and Volume Response of the Sigmoid in Radiotherapy of Gynecological Cancer

Alevront E; Lind H; al-Abany M; Waldenstrom AC; Olsson C; Dunberger G; Johansson KA; Avall-Lundqvist E; Steineck G; Lind BK
Editorial comment: ANNALS OF ONCOLOGY. 2005;16 Suppl 8:viii5-viii6

History, scope and methodology of the 3rd International Consensus Workshop on Ovarian Cancer 2004.

Quinn M; Avall-Lundqvist E; du Bois A; Vermorken J; Parmar M; Pfisterer J; Stuart G; Thigpen T; Neijt J
Letter: GYNECOLOGIC ONCOLOGY. 2003;89(2):339

Letter to the editor -: Reply

Silins I; Åvall-Lundqvist E; Dillner J; Frankendal B

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI